Condensed Consolidated Statements of Stockholders' Equity (Unaudited) - USD ($) $ in Thousands	Total	Common Stock	Retained Earnings	Accumulated Other Comprehensive Loss	Cumulative Effect, Period of Adoption, Adjustment	Cumulative Effect, Period of Adoption, Adjustment Retained Earnings
Balance at beginning of period at Oct. 31, 2018	$ 668,916	$ 105,601	$ 587,252	$ (23,937)	$ 864	$ 864
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Cash dividends paid on common stock	(72,009)		(72,009)
Issuance of shares for stock options exercised and restricted stock units vested	24,078	1,351	22,727
Stock-based compensation expense	10,258		10,258
Contribution of stock to a deferred compensation trust	1,404		1,404
Purchase of common stock	$ (22,675)	(403)	(22,272)
Accounting standards update [Extensible List]	us-gaap:AccountingStandardsUpdate201409Member
Other comprehensive loss	$ (2,731)			(2,731)
Net earnings	235,717		235,717
Balance at end of period at Aug. 02, 2019	843,822	106,549	763,941	(26,668)
Balance at beginning of period at May. 03, 2019	805,277	106,434	723,959	(25,116)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Cash dividends paid on common stock	(24,079)		(24,079)
Issuance of shares for stock options exercised and restricted stock units vested	1,074	126	948
Stock-based compensation expense	3,233		3,233
Purchase of common stock	(738)	(11)	(727)
Other comprehensive loss	(1,552)			(1,552)
Net earnings	60,607		60,607
Balance at end of period at Aug. 02, 2019	843,822	106,549	763,941	(26,668)
Balance at beginning of period at Oct. 31, 2019	859,578	106,742	784,885	(32,049)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Cash dividends paid on common stock	(80,683)		(80,683)
Issuance of shares for stock options exercised and restricted stock units vested	9,371	551	8,820
Stock-based compensation expense	10,322		10,322
Contribution of stock to a deferred compensation trust	2,568		2,568
Purchase of common stock	(2,102)	(29)	(2,073)
Other comprehensive loss	(2,527)			(2,527)
Net earnings	257,505		257,505
Balance at end of period at Jul. 31, 2020	1,054,032	107,264	981,344	(34,576)
Balance at beginning of period at May. 01, 2020	984,950	107,111	911,541	(33,702)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Cash dividends paid on common stock	(26,939)		(26,939)
Issuance of shares for stock options exercised and restricted stock units vested	3,592	162	3,430
Stock-based compensation expense	4,955		4,955
Purchase of common stock	(620)	(9)	(611)
Other comprehensive loss	(874)			(874)
Net earnings	88,968		88,968
Balance at end of period at Jul. 31, 2020	$ 1,054,032	$ 107,264	$ 981,344	$ (34,576)